AMJ Financial Wealth Management Acquires 2,270 Shares of AMETEK, Inc. (NYSE:AME)

AMJ Financial Wealth Management boosted its holdings in AMETEK, Inc. (NYSE:AMEFree Report) by 98.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,565 shares of the technology company’s stock after purchasing an additional 2,270 shares during the quarter. AMJ Financial Wealth Management’s holdings in AMETEK were worth $739,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of AMETEK by 1.9% during the first quarter. Vanguard Group Inc. now owns 24,608,566 shares of the technology company’s stock worth $3,277,369,000 after acquiring an additional 463,926 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of AMETEK by 4.2% during the 1st quarter. BlackRock Inc. now owns 16,215,102 shares of the technology company’s stock valued at $2,356,541,000 after purchasing an additional 658,629 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich grew its position in shares of AMETEK by 97,096.7% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 13,834,006 shares of the technology company’s stock valued at $2,239,449,000 after purchasing an additional 13,819,773 shares in the last quarter. FMR LLC increased its holdings in shares of AMETEK by 34.9% in the first quarter. FMR LLC now owns 10,042,152 shares of the technology company’s stock worth $1,459,426,000 after purchasing an additional 2,597,135 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of AMETEK by 61.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 6,393,918 shares of the technology company’s stock worth $929,229,000 after buying an additional 2,440,787 shares in the last quarter. 85.70% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at AMETEK

In other AMETEK news, Director Steven W. Kohlhagen sold 810 shares of the business’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $155.09, for a total value of $125,622.90. Following the completion of the sale, the director now directly owns 29,454 shares of the company’s stock, valued at approximately $4,568,020.86. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, Director Steven W. Kohlhagen sold 1,645 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $152.74, for a total transaction of $251,257.30. Following the transaction, the director now owns 30,264 shares in the company, valued at $4,622,523.36. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Steven W. Kohlhagen sold 810 shares of AMETEK stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $155.09, for a total value of $125,622.90. Following the completion of the sale, the director now owns 29,454 shares of the company’s stock, valued at $4,568,020.86. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 36,385 shares of company stock worth $5,815,520. Insiders own 0.72% of the company’s stock.

AMETEK Trading Down 0.5 %

NYSE:AME traded down $0.80 during mid-day trading on Monday, hitting $154.86. 106,437 shares of the stock traded hands, compared to its average volume of 987,839. The company has a quick ratio of 1.21, a current ratio of 1.86 and a debt-to-equity ratio of 0.22. AMETEK, Inc. has a 52 week low of $131.52 and a 52 week high of $164.75. The stock has a market capitalization of $35.74 billion, a price-to-earnings ratio of 28.20, a PEG ratio of 2.62 and a beta of 1.19. The firm’s 50 day moving average is $148.26 and its two-hundred day moving average is $152.25.

AMETEK (NYSE:AMEGet Free Report) last released its earnings results on Tuesday, October 31st. The technology company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.06. AMETEK had a return on equity of 18.19% and a net margin of 19.68%. The firm had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.66 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. On average, equities research analysts predict that AMETEK, Inc. will post 6.33 earnings per share for the current year.

AMETEK Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 22nd. Stockholders of record on Friday, December 8th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, December 7th. AMETEK’s dividend payout ratio is currently 18.12%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. StockNews.com initiated coverage on AMETEK in a research note on Thursday, October 5th. They issued a “buy” rating on the stock. Royal Bank of Canada upped their price target on shares of AMETEK from $183.00 to $186.00 and gave the company an “outperform” rating in a research note on Wednesday, November 1st. BNP Paribas assumed coverage on shares of AMETEK in a research note on Thursday, October 5th. They issued a “neutral” rating and a $159.00 price objective for the company. Seaport Res Ptn restated a “buy” rating on shares of AMETEK in a report on Monday, August 7th. Finally, Wells Fargo & Company increased their price target on shares of AMETEK from $180.00 to $185.00 and gave the company an “overweight” rating in a report on Wednesday, August 2nd. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $173.75.

Check Out Our Latest Stock Analysis on AMETEK

AMETEK Profile

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers.

Featured Articles

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.